Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
follitropin delta + menotropins
- Development stage
- Preclinical
- Lead developer
- Ferring Pharmaceuticals
- Modality
- Recombinant Proteins and Enzymes
- Administration
- Subcutaneous
01
Overview
**Follitropin delta + menotropins** is a combination used for controlled ovarian stimulation in women undergoing assisted reproductive technologies (ART), particularly in vitro fertilization (IVF), especially in women with reduced ovarian reserve (low anti-Müllerian hormone, AMH, levels)[1]. Follitropin delta is a recombinant human follicle-stimulating hormone (FSH) that selectively activates the FSH receptor to stimulate growth and maturation of ovarian follicles[2][4][5], while menotropins is a urinary-derived gonadotropin preparation that contains both FSH and luteinizing hormone (LH) activities, supporting both follicular maturation and ovulation[1][3][7]. The combination aims to enhance ovarian response, blastocyst yield, and egg quality beyond that achieved with follitropin delta alone in specific patient populations[1].
- Brand names
- RekovelleMenopur
- Other names
- follitropin delta + HP-hMGREKOVELLE + MENOPURfollitropin delta + highly purified human menopausal gonadotropin
02
Targets
FSHR (Follicle-stimulating hormone receptor)LHCGR (Luteinizing hormone/choriogonadotropin receptor)
Beyond the preview
Go deeper on follitropin delta + menotropins.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on follitropin delta + menotropins.